CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleLevered free cash flow is $51.16M, above the global median of $16.24M
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
635.41MUSDvs all stocks (USD)
Trailing P/E
6.23xRevenue (TTM)
361.51MUSDvs all stocks (USD)
Profit Margin
28.26%Beta
0.2090xvs all stocks
52-Week Change
407.90%vs all stocks
Market Capitalization
635.41MUSDvs all stocks (USD)
Enterprise Value
1.01BUSDvs all stocks (USD)
Trailing P/E
6.23xForward P/E
2.68xPEG Ratio
-0.0298xPrice to Sales (TTM)
1.76xEnterprise to Revenue
2.80xEnterprise to EBITDA
4.96xProfit Margin
28.26%Operating Margin
68.10%Return on Assets (TTM)
33.15%Revenue (TTM)
361.51MUSDvs all stocks (USD)
Revenue per Share (TTM)
2.23USDUpdated Jul 19, 2026Quarterly Revenue Growth
158.90%Gross Profit (TTM)
271.87MUSDvs all stocks (USD)
EBITDA (TTM)
208.61MUSDvs all stocks (USD)
Net Income (TTM)
102.18MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
158.87%Operating Cash Flow (TTM)
112.21MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
51.16MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 19, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Revenue
296.15MUSDFY2025 · Dec 31, 2025Operating Income
118.76MUSDvs all stocks (USD)
Pre-tax Income
70.03MUSDFY2025 · Dec 31, 2025Income Tax Expense
46.01MUSDFY2025 · Dec 31, 2025Net Income
24.02MUSDFY2025 · Dec 31, 2025EBIT
102.77MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
124.91MUSDFY2025 · Dec 31, 2025Research & Development
95.14MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
82.26MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
4.08MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
32.75MUSDFY2025 · Dec 31, 2025EPS (Basic)
0.1500USDFY2025 · Dec 31, 2025EPS (Diluted)
0.1500USDFY2025 · Dec 31, 2025Basic Shares Outstanding
161.84MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
161.84MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
24.02MUSDFY2025 · Dec 31, 2025Operating Cash Flow
130.69MUSDFY2025 · Dec 31, 2025Free Cash Flow
130.66MUSDDerived from operating cash flow minus capital expenditure. This filing charges 1.88M of depreciation against 34K of capital expenditure, and its own free-cash-flow line reads 127.01M.FY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
215.46MUSDFY2025 · Dec 31, 2025Income Tax Paid
3.54MUSDFY2025 · Dec 31, 2025Interest Paid
30.33MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
24.02MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
1.88MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
40.80MUSDFY2025 · Dec 31, 2025Stock-based Compensation
17.25MUSDFY2025 · Dec 31, 2025Other Non-cash Items
1.67MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
35.15MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
6.20MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
3.73MUSDFY2025 · Dec 31, 2025Capital Expenditures
-34.00KUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-34.00KUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025Long-term Debt Payments
0.00USDFY2025 · Dec 31, 2025Net Financing Cash Flow
0.00USDFY2025 · Dec 31, 2025Shares Outstanding
164.61MSharesUpdated Jul 19, 2026Float Shares
135.05MSharesUpdated Jul 19, 2026Shares Short
16.23MSharesUpdated Jul 19, 2026Short Ratio
6.74daysvs all stocks
Short % of Shares Outstanding
10.77%vs all stocks
% Held by Insiders
3.16%vs all stocks
% Held by Institutions
98.79%vs all stocks
Total Cash (MRQ)
220.47MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
1.34USDUpdated Jul 19, 2026Total Debt (MRQ)
597.36MUSDvs all stocks (USD)
Current Ratio (MRQ)
1.41xBook Value per Share (MRQ)
-1.32USDUpdated Jul 19, 2026Total Assets
396.90MUSDvs all stocks (USD)
Total Current Assets
274.18MUSDFY2025 · Dec 31, 2025Total Liabilities
658.74MUSDFY2025 · Dec 31, 2025Total Non-current Assets
122.72MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
416.52MUSDFY2025 · Dec 31, 2025Total Current Liabilities
242.22MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
215.46MUSDFY2025 · Dec 31, 2025Accounts Receivable
46.74MUSDFY2025 · Dec 31, 2025Accounts Payable
2.90MUSDFY2025 · Dec 31, 2025Short-term Debt
202.93MUSDFY2025 · Dec 31, 2025Deferred Revenue
1.11MUSDFY2025 · Dec 31, 2025Other Current Liabilities
9.41MUSDFY2025 · Dec 31, 2025Long-term Debt
394.87MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
21.65MUSDFY2025 · Dec 31, 2025Common Stock (Book)
163.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-1.67BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
-261.83MUSDvs all stocks (USD)
52-Week Low
0.7200USDUpdated Jul 19, 202652-Week High
5.78USDUpdated Jul 19, 202652-Week Change
407.90%vs all stocks
Beta
0.2090xvs all stocks
50-Day MA
3.87USDUpdated Jul 19, 2026200-Day MA
3.54USDUpdated Jul 19, 2026Avg 10-Day Volume
2.70MSharesUpdated Jul 19, 2026Avg 30-Day Volume
2.52MSharesUpdated Jul 19, 2026Diluted EPS (TTM)
0.6200USDUpdated Jul 19, 2026Other Income / Expense
-20.06MUSDFY2025 · Dec 31, 20251 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Within or Near the Altman Distress Zone
Debt is a large share of its assets, and large against its cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Levered free cash flow is $51.16M, above the global median of $16.24MNotable
Levered free cash flow (USD): 51,157,624Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Gkht Medical Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Lanzhou Foci Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
MiMedx Group, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Lionco Pharmaceutical Group Inc.
Tier 1ProductionApproval-Gated PipelineRule
Hefei Lifeon Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Jinling Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Cerus Corporation
Tier 1ProductionApproval-Gated PipelineRule
Shenzhen Neptunus Bioengineering Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
476830
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Kinetic Medical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Delivery Hero SE
1 interpretationWithin or Near the Altman Distress Zone
Aveanna Healthcare Holdings Inc.
1 interpretationWithin or Near the Altman Distress Zone
GS Engineering & Construction Corporation
1 interpretationWithin or Near the Altman Distress Zone